Cas No.: | 923590-37-8 |
Chemical Name: | Cyclopropanecarboxamide, N-[[[6-(2-carboxy-2,3-dihydro-1H-isoindol-4-yl)-2,2-dimethylhexyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethyl-, (12)-lactone, (1R,2R)- |
Synonyms: | MK-7009;MK7009;MK 7009 |
SMILES: | CC([C@H]1C(=O)N2C[C@@H](C[C@H]2C(N[C@@]2(C(NS(C3CC3)(=O)=O)=O)[C@@H](CC)C2)=O)OC(=O)N2CC3C(C2)=CC=CC=3CCCCC(C)(C)COC(=O)N1)(C)C |
Formula: | C38H55N5O9S |
M.Wt: | 757.9364 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A potent, selective, orally available inhibitor of HCV NS3/4A protease with Ki of 0.05 and 0.9 nM for GT1b and 2a protease, respectively; displays excellent selectivity against both a range of human proteases and a broad panel of pharmacologically relevant targets; has replicon EC50 of 3 and 9 nM for GT1b and 2a, respectively, has good plasma exposure and excellent liver exposure in multiple species.HCV InfectionApproved |